The stock's fall snapped a three-day winning streak.

Henry Schein Inc. closed 10.96% short of its 52-week high of $82.49, which the company reached on February 5th.

Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 13 Cheap Mid-Cap Stocks to Add to Your Portfolio. On June 16, Leerink Partners ...

According to Benzinga Pro, Henry Schein's peer group average for short interest as a percentage of float is 4.30%, which means the company has more short interest than most of its peers. Did you know ...

Medical supplies distributor Henry Schein Inc on Monday missed first-quarter revenue estimates, hurt by muted demand for its dental products amid rising inflation.

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Henry Schein Inc. (HSIC) on Monday reported first-quarter profit of $110 million. On a per-share basis, the Melville, New York-based company said it ...

Henry Schein Medical announced today that Ian Jeffer, Head Athletic Trainer at Desert Ridge High School, is the winner of the fifth annual Henry Schein Medical Athletics and Schools Rising Star Award.

Henry Schein announces executive role changesThe information in this article is based on a press release statement filed with the SEC. In other recent news, Henry Schein Inc. reported its Q4 2024 ...

Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic ...